Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.5_suppl.131
Abstract: 131Background: Oncological immune checkpoint inhibitors (CPI) commonly cause immune related adverse events (irAEs). Thyroid irAEs have a significant clinical impact requiring therapeutic intervention and clinical coordination whilst often causing treatment delays. Methods: Retrospective review of…
read more here.
Keywords:
melanoma;
clinical trajectories;
distinct clinical;
checkpoint ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvab048.1730
Abstract: Introduction: Thyroid immune-related adverse events (irAEs) occur frequently after immune checkpoint inhibitor (ICI) cancer therapy, but their risk factors and potential influence on survival need further investigation. Methods: We performed a retrospective single-center cohort study…
read more here.
Keywords:
thyroid immune;
cancer;
thyroid iraes;
hypothyroidism ... See more keywords